Inogen, Inc.

NasdaqGS:INGN Stock Report

Market Cap: US$180.5m

Inogen Management

Management criteria checks 2/4

Inogen's CEO is Kevin R. Smith, appointed in Nov 2023, has a tenure of 2.17 years. total yearly compensation is $4.16M, comprised of 17% salary and 83% bonuses, including company stock and options. directly owns 0.32% of the company’s shares, worth $573.84K. The average tenure of the management team and the board of directors is 2 years and 3.8 years respectively.

Key information

Kevin R. Smith

Chief executive officer

US$4.2m

Total compensation

CEO salary percentage16.96%
CEO tenure2.2yrs
CEO ownership0.3%
Management average tenure2yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Slow Progress At Inogen ... But Progress All The Same

Nov 11

There's No Escaping Inogen, Inc.'s (NASDAQ:INGN) Muted Revenues Despite A 29% Share Price Rise

Aug 31
There's No Escaping Inogen, Inc.'s (NASDAQ:INGN) Muted Revenues Despite A 29% Share Price Rise

Analysts Have Been Trimming Their Inogen, Inc. (NASDAQ:INGN) Price Target After Its Latest Report

May 10
Analysts Have Been Trimming Their Inogen, Inc. (NASDAQ:INGN) Price Target After Its Latest Report
User avatar

Yuwell Collaboration Will Open Chinese Respiratory Market

Strategic partnerships and product innovation in China and digital health are expected to drive growth and improve earnings potential.

Why Investors Shouldn't Be Surprised By Inogen, Inc.'s (NASDAQ:INGN) 35% Share Price Plunge

Mar 08
Why Investors Shouldn't Be Surprised By Inogen, Inc.'s (NASDAQ:INGN) 35% Share Price Plunge

A Volatile Share Price Masks Some Of The Progress At Inogen

Mar 01

Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.00

Feb 28
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.00

Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 32%

Jan 22
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 32%

Inogen: Upside Seems Limited After Big Move Up

Sep 24

Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jul 16
Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Inogen: Improving, But Still Struggling For Air

Jul 01

Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

May 22
Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities

Apr 13

Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Mar 01
Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Feb 01
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Oct 06
Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Jun 21
Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Mar 14
Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

CEO Compensation Analysis

How has Kevin R. Smith's remuneration changed compared to Inogen's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$25m

Jun 30 2025n/an/a

-US$26m

Mar 31 2025n/an/a

-US$27m

Dec 31 2024US$4mUS$705k

-US$36m

Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$92m

Mar 31 2024n/an/a

-US$97m

Dec 31 2023US$2mUS$108k

-US$102m

Compensation vs Market: Kevin R.'s total compensation ($USD4.16M) is above average for companies of similar size in the US market ($USD1.44M).

Compensation vs Earnings: Kevin R.'s compensation has increased whilst the company is unprofitable.

CEO

Kevin R. Smith (54 yo)

2.2yrs
Tenure
US$4,159,779
Compensation

Mr. Kevin R. M. Smith serves as President, Chief Executive Officer and Director at Inogen Inc. since November 13, 2023. He served as Director at OncoSec Medical Incorporated since February 7, 2020 until Ju...

Leadership Team

NamePositionTenureCompensationOwnership
Kevin R. Smith
President2.2yrsUS$4.16m0.32%
$ 573.8k
Michael Bourque
Executive VP1.8yrsUS$1.89m0.18%
$ 326.8k
Kevin Smith
General Counsel1.5yrsUS$977.99k0.047%
$ 85.0k
Grgoire Ramade
Executive VP & Chief Commercial Officer2yrsUS$874.12kno data
Philip Corrin
Senior Vice President of Operations & Supply Chain2.9yrsno datano data
Mary Wright
Chief Accounting Officerless than a yearno data0.045%
$ 81.0k
Naga Rameswamy
Chief Technology Officerless than a yearno datano data
Lorna Williams
Senior Vice President of Investor Relationsno datano datano data
Jennifer Boyer
Executive VP of Enterprise Enablement & Chief Human Resources Officer3.7yrsno data0.050%
$ 89.8k
Krishna Jhaveri
Chief Medical Officer2yrsno datano data
Paul Andreassi
Senior Vice President of Quality & Regulatory Affairs2yrsno datano data
Adrien Mithalal
Senior Vice President of Research & Development2yrsno datano data
2.0yrs
Average Tenure
54yo
Average Age

Experienced Management: INGN's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kevin R. Smith
President2.2yrsUS$4.16m0.32%
$ 573.8k
Richard Casaburi
Member of Advisory Boardno datano datano data
Jeffrey Kupperman
Member of Advisory Boardno datano datano data
Paul Selecky
Member of Advisory Boardno datano datano data
Mary Ladone
Independent Director3.8yrsUS$248.76k0.090%
$ 162.3k
Kevin King
Independent Director3.8yrsUS$245.82k0.17%
$ 307.7k
Neil MacIntyre
Member of Advisory Boardno datano datano data
Elizabeth Mora
Independent Board Chairperson4.7yrsUS$312.91k0.18%
$ 323.0k
Robert Chatburn
Member of Advisory Boardno datano datano data
Heather Rider
Independent Director11.4yrsUS$242.50k0.21%
$ 383.0k
Glenn Boehnlein
Independent Director3.8yrsUS$250.00k0.17%
$ 307.7k
Mira Sahney
Independent Director1yrno data0.034%
$ 60.6k
3.8yrs
Average Tenure
63yo
Average Age

Experienced Board: INGN's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 02:51
End of Day Share Price 2026/01/06 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Inogen, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anderson SchockB. Riley Securities, Inc.
Matthew MishanKeyBanc Capital Markets Inc.
Jeffrey CohenLadenburg Thalmann & Company